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BRIEF OBSERVATIONS
Influenza Vaccination
Coverage among Adults
with Asthma: Findings
from the 2000 Behavioral
Risk Factor Surveillance
System
Earl S. Ford, MD, MPH, Seymour G. Williams, MD,
David M. Mannino, MD, Stephen C. Redd, MD
The prevalence of asthma has increased substan-tially in the United States since 1980 (1). The pri-mary clinical and public health strategy to reduce
the burden of asthma is to prevent exacerbation of the
disease, of which upper and lower respiratory tract infec-
tions are a major cause (2–5). One such infection—influ-
enza—and its complications are potentially preventable
with annual vaccination, which is a safe and effective
method (6,7), including among persons with asthma (8).
Because persons with asthma are at increased risk of com-
plications from influenza, they are advised to receive an-
nual influenza vaccinations (9), unless there are contra-
indications.
Little is known about how adults with asthma or health
care providers comply with the annual influenza vaccina-
tion recommendations issued by the Advisory Commit-
tee on Immunization Practices (9). Among children with
asthma, however, vaccination levels are low (10 –15). We
therefore sought to assess the influenza vaccination cov-
erage among adults with asthma, as well as to identify
predictors of receiving such a vaccination.
METHODS
Data are from the 2000 Behavioral Risk Factor Surveil-
lance System, an annual standardized state-based tele-
phone survey of risk factors for chronic disease (16).
Health agencies in the 50 states, the District of Columbia,
and three U.S. territories (Guam, Puerto Rico, and the
Virgin Islands) selected for interview an independent
probability sample of noninstitutionalized adult resi-
dents aged 18 years who were living households that
had telephones. All states used an identical core question-
naire administered over the telephone by trained inter-
viewers. The survey was reviewed and approved by the
human subjects office at the Centers for Disease Control
and Prevention.
Respondents were asked, “Did a doctor ever tell you
that you had asthma?” Those who responded “yes” were
then asked, “Do you still have asthma?” Respondents who
answered affirmatively to both questions were classified
as having “current” asthma. In 17 states, participants
were also asked, “During the past 12 months, have you
had a flu shot?”
We examined the percentages of participants with
asthma who reported having an influenza vaccination, by
age, sex, race or ethnicity, and education. Direct age ad-
justment was performed using the age distribution of the
U.S. population in 2000. We used logistic regression anal-
ysis to examine the independent associations of age, sex,
race or ethnicity, education, health status, health insur-
ance status, time since the last checkup, and state of origin
with vaccination status. Health status was determined
from the question “Would you say that in general your
health is excellent, very good, good, fair, or poor?” Insur-
ance status was determined from four questions. Time
since the last checkup was determined from the question
“About how long has it been since you last visited a doctor
for a routine checkup?” Answers included the following:
within the past year (1 to 12 months ago), within the past
2 years (1 to 2 years ago), within the past 5 years (2 to 5
years ago), 5 or more years ago, and never.
Statistical Analysis
Analyses were conducted with SUDAAN (Research Tri-
angle Institute, Research Triangle Park, North Carolina)
to produce valid estimates of the variance (17).
RESULTS
From 17 states, we included in our analysis 3939 partici-
pants with current asthma who were aged18 years and
had complete data. The mean age was 45 years (range, 18
to 96 years); 40% were men; 83% were white; and the
mean length of education was 14 years.
Overall, 41% of participants with asthma reported
having received an influenza vaccination during the pre-
ceding year. Influenza vaccination levels were 27%
among participants aged 18 to 49 years, 56% among those
aged 50 to 64 years, and 75% among those aged 65
years.
In univariate analyses, age, sex, race or ethnicity, health
status, medical insurance, and time since the last physi-
cian visit were associated with vaccination status (P 
0.05 for sex; 0.001 for all other variables); education
was not (P 0.30). In a multivariate analysis, all of these
univariate associations, except for sex, continued to be
significant (Table 1). In addition, after adjusting for age
(and other variables), higher levels of education were as-
sociated with being vaccinated (Table 1).
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Influenza vaccination levels varied almost twofold
among the states that had included the influenza vaccina-
tion question in their surveys (Table 2): South Dakota
(61%) had the highest coverage and New Jersey (32%)
had the lowest. After adjusting for the variables in Table 1,
these differences among states remained (P 0.001).
DISCUSSION
We found that influenza vaccination levels were generally
low among adults with asthma. Only 41% of adults with
asthma reported being vaccinated during the previous
year: 27% of participants aged 18 to 49 years, 56% of
those aged 50 to 64 years, and 75% of those aged 65
years. Furthermore, there was substantial interstate vari-
ation in the percentage of participants who were vacci-
nated. During 1999 to 2001, vaccination levels in the gen-
eral population ranged from 64% to 68% among people
aged65 years and from 32% to 38% among those aged
50 to 64 years (9).
Influenza and asthma are important sources of mor-
bidity and mortality in the United States. Each year,
about 114,000 excess hospitalizations and 36,000 deaths
are attributed to influenza (9). In 1999, about 10.5 mil-
lion people reported having one or more asthma attacks
during the past 12 months (1). Influenza may be respon-
sible for as many as 19% of asthma attacks or exacerba-
tions in children and adults (2,18,19). Because inacti-
vated influenza vaccine may prevent about 70% to 90% of
influenza illnesses among people aged 65 years during
Table 1. Characteristics Associated with Influenza Vaccination among Persons with Asthma
Variable
Number of
Participants
Number
Vaccinated (%)*
Adjusted Odds Ratio†
(95% Confidence Interval)
Age (years)
18–49 2306 670 (27) 1.0
50–64 900 512 (56) 2.8 (2.1–3.7)
65 733 544 (75) 5.0 (3.0–8.4)
Sex
Male 1134 472 (37) 1.0
Female 2805 1254 (43) 1.2 (0.9–1.6)
Race or ethnicity
White 3255 1490 (44) 1.0
African American 363 122 (28) 0.5 (0.3–0.7)
Mexican American 169 55 (27) 0.6 (0.4–1.0)
Other 152 59 (46) 1.0 (0.6–1.9)
Education
High school 569 286 (44) 1.0
High school/general
equivalency diploma
1212 487 (38) 1.1 (0.8–1.7)
Some college 1188 521 (40) 1.6 (1.1–2.4)
Postgraduate 970 432 (45) 2.2 (1.4–3.5)
Health status
Excellent 469 167 (37) 1.0
Very good 1081 411 (32) 0.9 (0.6–1.4)
Good 1253 535 (41) 1.2 (0.8–1.8)
Fair 696 350 (44) 1.3 (0.8–2.1)
Poor 440 263 (66) 2.4 (1.3–4.3)
Insurance
Private 2320 911 (36) 1.00
Medicare 1008 673 (66) 1.4 (0.8–2.2)
Medicaid 234 82 (40) 1.1 (0.6–1.8)
None 377 60 (18) 0.5 (0.3–0.8)
Time since last checkup (years)
1 3107 1498 (46) 1.0
1–2 387 119 (33) 0.8 (0.5–1.3)
2–5 196 56 (27) 0.6 (0.4–1.2)
5 230 49 (24) 0.5 (0.3–0.9)
Never 19 4 (16) 0.2 (0.0–1.0)
* Percentages were calculated using sampling weights. Standard errors range from 2% to 10%.
† Adjusted for all variables shown in Table.
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the years when the vaccine and circulating influenza
strain match (9), vaccination could substantially reduce
influenza-associated morbidity among persons with
asthma.
Estimating the excess morbidity, mortality, and health
care use among persons with asthma who do not receive
an influenza vaccination is difficult because the benefits
to patients with asthma have not been well established
and the cost-effectiveness of routinely vaccinating people
with asthma is not well defined (20). A recent study
showed that the vaccine effectiveness in reducing hospi-
talizations for pneumonia and influenza or all-cause
mortality ranged from 27% to 48% among persons aged
65 years with lung conditions that included asthma
(21).
Our analysis of data from the Behavioral Risk Factor
Surveillance System shows that 73% of participants with
asthma reported seeing a provider during the past 12
months. For those who do see a health care provider on a
regular basis, opportunities exist for physicians and their
staff to discuss the need for vaccination or to administer
the vaccine. Furthermore, there is a range of patient-,
provider-, and system-specific strategies for improving
vaccination coverage, including sending computerized
reminder letters, implementing patient reminder/recall
systems, and using audit and feedback (22–24). The Cen-
ters for Disease Control and Prevention has summarized
strategies for improving vaccination coverage among
adults (25). In addition, physicians may need to address
other concerns about influenza vaccination that are more
specific to persons with asthma, such as effects of the
vaccine while taking inhaled corticosteroids or increased
risk of allergic reactions to vaccine components.
Some of the predictors of vaccination status that we
found, such as age, health status, and medical insurance,
have been described by others (26,27). Thus, to reach
groups with low coverage of influenza vaccination, inter-
ventions should be aimed at young adults, African Amer-
icans, Mexican Americans, and those without insurance.
The variation in vaccination levels among states suggests
that states with higher levels may employ strategies that
other states could use to improve their vaccination levels.
Several limitations should be considered when inter-
preting our results. All data were self-reported and sub-
ject to misclassification; however, the validity of self-re-
ported asthma (28 –30) and influenza vaccination status
(31–35) has been demonstrated. Because our results are
based on the 17 states that administered the question
about influenza vaccination, these results are not nation-
ally representative. Additionally, the survey did not in-
clude institutionalized adults and households without
telephones.
In general, influenza vaccination levels have increased
among adults aged 65 years in the United States,
although the trend among people with asthma is un-
known (9). Should the general favorable trend continue,
progress will be made in achieving the objectives of the
Healthy People 2010, which call for 90% of noninstitu-
tionalized adults aged65 years and 60% of noninstitu-
tionalized high-risk adults (including persons with
asthma) aged 18 to 64 years to undergo annual influenza
vaccinations (36).
Table 2. Influenza Vaccination Coverage among Persons with Asthma, by State
State
Number of
Participants
Number
Vaccinated (%)*
Adjusted Odds Ratio†
(95% Confidence Interval)
South Dakota 274 168 (61) 2.9 (1.8–4.7)
Nebraska 195 101 (51) 1.9 (1.2–3.1)
North Dakota 135 61 (49) 2.0 (1.1–3.6)
Arizona 198 86 (48) 1.6 (0.8–3.0)
Minnesota 206 98 (46) 1.6 (1.0–2.6)
South Carolina 231 110 (46) 1.9 (1.2–3.2)
Tennessee 233 102 (46) 1.3 (0.8–2.2)
North Carolina 217 102 (45) 1.5 (0.9–2.4)
Vermont 256 115 (44) 1.6 (1.0–2.5)
Iowa 227 107 (42) 1.4 (0.9–2.3)
Virginia 129 56 (42) 1.8 (1.1–3.1)
California 299 124 (41) 1.7 (1.1–2.8)
Ohio 263 90 (38) 1.3 (0.8–2.1)
Kansas 329 128 (37) 1.1 (0.7–1.7)
Montana 245 109 (37) 1.2 (0.7–2.1)
Georgia 258 94 (33) 1.1 (0.7–1.9)
New Jersey 244 75 (32) 1.0 (Reference)
* Percentages were calculated using sampling weights. Standard errors range from 2% to 10%.
† Adjusted for age, sex, race or ethnicity, education, health status, insurance, and time since last checkup.
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